Physician profile
Christopher S Thomas
NPI 1891921557
$5,159.17
in general payments reported to CMS, 2019-2025
42 companies · $836 in 2025
The $836 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $220 · 2021: $682 · 2022: $630 · 2023: $985 · 2024: $1,077 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,897.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,282.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $693.09 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $507.35 | 2019-2025 | Lifevest |
| Amgen INC. | $349.21 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.92 | 2019-2025 | Jardiance |
| Pfizer INC. | $232.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $193.26 | 2019-2024 | Farxiga |
| Philips North America LLC | $173.63 | 2024-2025 | Diagnostic Ecg Service, Holter, (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $159.51 | 2022-2024 | Verquvo |
| Novo Nordisk INC | $129.17 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Medtronic, INC. | $112.56 | 2021 | |
| Alnylam Pharmaceuticals INC. | $111.59 | 2023-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $97.39 | 2019-2024 | Eliquis |
| Abbott Laboratories | $81.32 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $70.81 | 2023-2024 | Optimizer, Optimizer |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.